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The human chitinase, named chitotriosidase, is a
member of family 18 of glycosylhydrolases. Following
the cloning of the chitotriosidase cDNA (Boot, R. G.,
Renkema, G. H., Strijland, A., van Zonneveld, A. J., and
Aerts, J. M. F. G. (1995) J. Biol. Chem. 270, 26252–26256),
the gene and mRNA have been investigated. The chito-
triosidase gene is assigned to chromosome 1q31-q32. The
gene consists of 12 exons and spans about 20 kilobases.
The nature of the common deficiency in chitotriosidase
activity is reported. A 24-base pair duplication in exon
10 results in activation of a cryptic 3* splice site, gener-
ating a mRNA with an in-frame deletion of 87 nucleo-
tides. All chitotriosidase-deficient individuals tested
were homozygous for the duplication. The observed car-
rier frequency of about 35% indicates that the duplica-
tion is the predominant cause of chitotriosidase defi-
ciency. The presence of the duplication in individuals
from various ethnic groups suggests that this mutation
is relatively old.
A chitinase in man has been documented only recently (1–3).
The enzyme was detected initially on the basis of its capacity to
hydrolyze artificial chitotrioside substrates and was therefore
named chitotriosidase (1). Chitotriosidase is synthesized by
activated macrophages (1). In plasma and tissues of patients
suffering from Gaucher disease, chitotriosidase activity is
markedly elevated because of its massive production and se-
cretion by the lipid-laden macrophages that accumulate in
these patients (1, 4). Purification of chitotriosidase and cloning
of the corresponding cDNA have revealed that the enzyme
belongs to the family 18 of glycosylhydrolases and shares sig-
nificant sequence identity to chitinases from various nonmam-
malian species (3, 5). The enzyme is capable of degrading chitin
and should be considered as the human chitinase analogue (2).
The established antifungal action of homologous chitinases in
plants and the tightly regulated expression of chitotriosidase in
phagocytes suggest that chitotriosidase might fulfill a role in
degradation of chitin-containing pathogens (6, 7). Recently, a
number of other human members of the chitinase protein fam-
ily have been identified: oviductin (human oviduct specific gly-
coprotein), human cartilage glycoprotein 39 (HCgp-39), and
YKL39 (8–10). In contrast to chitotriosidase, these proteins
have no known enzymatic activity, and their function is so far
not precisely understood.
Chitotriosidase in human tissue is heterogeneous with re-
spect to its isoelectric point and molecular mass. The major
isoform shows a molecular mass of 50 kDa and a heterogeneous
pI of 5.0–7.2. The minor isoform has a mass of 39 kDa and a
discrete pI of 8.1 (2). The amino termini of both isoforms are
identical and exactly as predicted by the cloned chitotriosidase
cDNA that codes for a 50-kDa protein. Metabolic labeling ex-
periments with cultured macrophages have revealed that a
50-kDa chitotriosidase is initially synthesized and subse-
quently undergoes posttranslational modification. First,
O-linked glycosylation of the carboxyl-terminal part of the pro-
tein generates the heterogeneity in charge. Second, whereas
most 50-kDa enzyme is secreted, part of it is intracellularly
converted by carboxyl-terminal proteolytic processing into the
39-kDa isoform that accumulates in lysosomes (11). It has
recently been noted that the carboxyl-terminal domain of 50-
kDa chitotriosidase mediates the strong binding of this enzyme
to chitin, a feature that is not shown by the 39-kDa enzyme
(11).
A recessively inherited deficiency in chitotriosidase activity
is frequently encountered (1). For example, in The Netherlands
about 1 in 20 individuals is completely deficient in enzymati-
cally active chitotriosidase in all materials tested, including
plasma, urine, cultured macrophages, leukocytes, and tissues
(1, 12). Because there are no indications for the presence of
enzyme inhibitors in these individuals, it is most likely that
some mutation in the chitotriosidase gene underlies the en-
zyme deficiency.
To obtain further insight in the molecular basis of the chito-
triosidase deficiency, we have investigated the composition of
the chitotriosidase gene and the corresponding mRNA of con-
trol and enzyme-deficient individuals. The results of this study
are here described and discussed.
MATERIALS AND METHODS
Reagents and Cells—All reagents were obtained from Sigma unless
indicated otherwise. Peripheral blood monocytes were isolated and cul-
tured for a prolonged time in the presence of human AB serum during
which process spontaneous differentiation into macrophages occurs (1).
After 7–14 days of culture, cells were used in experiments.
Metabolic Labeling—Cultured macrophages or transfected COS cells
were incubated for 10 min in the presence of radioactive methionine and
subsequently chased in the presence of excess unlabeled amino acid.
Radiolabeled chitotriosidase was specifically visualized using a rabbit
anti-(chitotriosidase) antiserum exactly as described before (2, 11).
Binding of chitotriosidase to chitin was analyzed by incubation of en-
zyme containing samples with chitin particles (Sigma), followed by
centrifugation.
cDNA Cloning and Sequence Analysis—A macrophage cDNA library,
was screened using the partial chitotriosidase cDNA probe (3). Positive
cDNA clones were sequenced double-stranded using the dideoxy-nucle-
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otide chain termination method with T7 DNA polymerase (Amersham
Pharmacia Biotech, Uppsala, Sweden) and appropriate primers as de-
scribed (3, 13, 14).
RNA Isolation and Northern Blot Analysis—Total macrophage RNA
was isolated using the RNAzol B RNA isolation kit according to the
instructions of the manufacturer (Biosolve, Barneveld, The Nether-
lands). For Northern blot analysis, 15-mg samples of total RNA were
electrophoresed in 10 mM Hepes, 6% formaldehyde-agarose gels, trans-
ferred to Hybond N nylon membranes (Amersham, UK) by the capillary
method and immobilized by UV cross-linking. The following probes
were used: total chitotriosidase cDNA and mouse glyceraldehyde-3-
phosphate dehydrogenase as an RNA control. The probes were radiola-
beled with 32P using the random priming method (13). Hybridization
conditions were exactly as described before (3).
Isolation of a Genomic Chitotriosidase Clone—A human genomic
library (Imperial Cancer Research Fund (ICRF), Reference Library
(library no. 700 P1 Human, host NS3145, vector pAd10SacBII (15)) was
screened using the full-length 32P-labeled chitotriosidase cDNA probe.
Duplicate filters were used in the screening procedure to avoid false
results. The hybridization conditions were exactly as described before
(3). The coordinates of the positive spots on the filters were determined,
and the genomic clone (ICRFP700O0516) containing the chitotriosidase
gene was obtained from the ICRF. The genomic clone was digested with
different restriction enzymes, and the smaller fragments, containing
exons, were subcloned in the plasmid vectors pGEM-7Zf(1) (Promega,
Madison, WI) or pUC19 (New England Biolabs Inc.). Sequence analysis
on the plasmid subclones was performed as described above, using
several primers specific for the chitotriosidase cDNA.
Localization of Chitotriosidase Gene—The obtained genomic chito-
triosidase clone of about 110 kb was biotinylated by nick translation
according to the specifications of the manufacturers (Life Technologies,
Inc.). High resolution chromosomes from peripheral blood lymphocytes
were obtained according to standard techniques. Fluorescent in situ
hybridization (FISH) was performed using the biotinylated genomic
clone and fluorescein isothiocyanate-conjugated avidin, exactly as de-
scribed before (16). For chromosome identification and probe localiza-
tion, metaphases were simultaneously Q-banded using DAPI1/actino-
mycin D, as described (17).
RNase Protection Analysis—To generate the desired RNase protec-
tion probe, a polymerase chain reaction (PCR) fragment of chitotriosi-
dase (216 bp), was ligated into the EcoRV site of pGEM-5Zf(1) (Pro-
mega). To determine the orientation and to exclude the existence of
PCR artifacts, this construct was sequenced. The plasmid was then
linearized with NdeI and size fractionated on an agarose gel, and the
appropriate fragment was isolated. The protection riboprobe (298 nu-
cleotides) was generated using this DNA template, T7 RNA polymerase
(Stratagene), and [32P]UTP. After in vitro transcription, the RNA was
purified by electrophoresis on a 5% polyacrylamide, 7 M urea, TBE (0.09
M Tris borate, 0.002 M EDTA, pH 8.0) gel, and the appropriate band was
isolated (13, 18).
For RNase protection, 5 mg of total macrophage RNA was hybridized
overnight at 42 °C with 105 cpm of labeled probe in 20 ml of 80%
formamide, 400 mM NaCl, 40 mM PIPES, pH 6.4, 1 mM EDTA. Follow-
ing hybridization, single-stranded RNA was digested in 350 ml of 10 mM
Tris-HCl, pH 7.5, 300 mM NaCl, 5 mM EDTA, 1 mg/ml RNase T1 (1300
units/mg, Life Technologies, Inc.) for 60 min at 37 °C. Next, RNA was
purified by Proteinase K digestion, phenol/chloroform/isoamylalcohol
extraction, and ethanol precipitation. Finally, RNA was visualized by
autoradiography after electrophoresis on a 5% polyacrylamide, 7 M
urea, TBE gel (13, 18).
Computer Analysis—Sequence analysis of cDNA clones, genomic
clone and subclones, was performed using Mac Vector 4.1.1 and the
Genetics Computing Group package (version 7.0). Sequence compari-
sons and multiple sequence alignments were performed using the se-
quence alignment programs PILEUP, BESTFIT, and GAP.
Activity Measurement and Immunotitration of Recombinant Chito-
triosidase—Transient transfection of COS-1 cells by the DEAE-dextran
method was performed essentially as described in Ref. 19. The activity
of chitotriosidase was measured using the fluorogenic substrate
4-methylumbelliferyl b-D-N,N9,N0-triacetylchitotriose exactly as de-
scribed before (1). A rabbit antiserum was raised against 39-kDa chi-
totriosidase purified from human spleen. This antiserum is able to
inhibit human chitotriosidase in enzymatic activity (2). Immunotitra-
tions were carried out as follows. Enzyme-containing samples were
preincubated for 30 min with different amounts of antiserum, and
subsequently enzyme activity was determined in the samples. For these
experiments, medium from transfected COS cells was collected and
cells were harvested by trypsinization. Cells were homogenized by
sonication in 0.25% (v/v) Triton X-100, 50 mM potassium phosphate
buffer (pH 6.5). The homogenate was centrifuged and the supernatant
collected. As a control enzyme preparation, an extract of Gaucher
spleen was prepared by addition of 5 volumes of H2O and homogeniza-
tion with an Ultraturrax (Janke & Kunkel, Staufen, Germany). The
supernatant obtained after centrifugation was collected.
RNA Extraction and Reverse Transcription-PCR—From harvested
macrophages, total RNA was isolated and single-stranded cDNA was
prepared from the total macrophage RNA using reverse transcriptase
and oligo(dT) as described before (3). To obtain the complete open
reading frame of chitotriosidase, PCR was carried out using the single-
stranded cDNA as template as described before (3). The primers used
are: Chs1, 59-CTGCATCATGGTGCGGTC-39; and Chas1, 59-GAAG-
GCAAGGCTGAGAGC-39 (see Fig. 3B). The PCR products were subse-
quently cloned in the pGEM-T vector (Promega). Sequence analysis of
the cloned PCR products was performed exactly as described above.
Amplification of Genomic DNA—Genomic DNA was isolated from
leukocytes, and 300 ng of this genomic DNA was used as template in
subsequent PCR reactions. The following primers were employed: Chs8,
59-TACATCTTCCGGGACAAC-39; and Chas9, 59-TCAGTTCCTGCCG-
TAGCGTC-39. PCR fragments were cloned in the pGEM-T vector and
sequenced as described above.
Duplication Mutation Analysis—Using specific primers (Chs9, 59-
AGCTATCTGAAGCAGAAG-39; and Chas8, 59-GGAGAAGCCGGCA-
AAGTC-39, see Fig. 4) fragments of 75 and 99 bp are amplified from the
normal and mutant chitotriosidase gene, respectively, when present in
genomic DNA. Electrophoresis in a native 10% acrylamide gel allows
the detection of both fragments. In the case of carriers for the duplica-
tion, a mixture of both fragments is detected.
RESULTS
Characterization of the Human Chitotriosidase Gene—A
genomic clone containing the chitotriosidase gene was isolated
(clone ICRFP700O0516 of the Imperial Cancer Research Fund
Reference Library (15)), as described under “Materials and
Methods.” To allow sequence analysis, the genomic clone of
about 110 kb was subcloned into smaller fragments using Hin-
dIII and BamHI restriction enzymes.
The exon/intron composition of the chitotriosidase gene was
determined by sequencing of genomic plasmid subclones and
comparison of the information with the sequence of the chito-
triosidase cDNA. As shown in Fig. 1, the gene was found to be
composed of 12 exons and spans about 20 kb of genomic DNA.
Exon 1 was defined as containing the first nucleotide of the
longest chitotriosidase cDNA; the exact transcription start site
has not been accurately mapped. The sizes of the exons range
1 The abbreviations used are: DAPI, 4,6-diamidino-2-phenylindole;
PCR, polymerase chain reaction; bp, base pair(s); kb, kilobase(s);
PIPES, 1,4-piperazinediethanesulfonic acid.
FIG. 1. The genomic organization of the chitotriosidase gene. Shown is the genomic structure. E1–E12 are exons defined on the basis of
the cloned cDNAs. The location of the HindIII sites within the gene are indicated with “H” and the BamHI sites with “B.” The translation initiation
site is indicated (ATG). The alternative exon is indicated in black (see “Results”).
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from 30 to 461 bp. The sizes of the smaller introns were deter-
mined by sequencing, and those of the larger ones were esti-
mated by electrophoresis of fragments generated either by PCR
or restriction enzyme digestion (Table I). In all cases, the se-
quences of the intron/exon borders are compatible with consen-
sus splice site sequences (20).
The 71-bp exon 11 can be alternatively spliced (Fig. 1). This
exon is usually skipped in the splicing process, generating the
predominant mRNA species encoding the 50-kDa protein. In
macrophages also, a distinct mRNA is rarely formed as the
result of a lack of exon 11 skipping. Since exon 11 introduces a
premature stop codon, the alternatively spliced mRNA encodes
a 40-kDa chitotriosidase that is almost identical to the 39-kDa
isoform generated by proteolytic processing of the 50-kDa
chitotriosidase (11).
Fluorescent in situ hybridization with the genomic clone as
probe was used to assign the chromosomal locus for the chito-
triosidase gene, as described under “Materials and Methods.”
Fig. 2 shows that the chitotriosidase gene is located on chro-
mosome 1q31–1q32.
Genetic Basis of Chitotriosidase Deficiency—Cultured macro-
phages of enzyme-deficient individuals do not produce enzy-
matically active chitotriosidase. Metabolic labeling experi-
ments showed that only minor amounts of a short-lived 47-kDa
chitotriosidase are synthesized (not shown). Northern blot
analysis revealed that these macrophages do contain some
chitotriosidase RNA although in markedly reduced amounts
(Fig. 3A). From macrophage RNA of two control subjects and
two unrelated chitotriosidase-deficient individuals, chitotriosi-
dase cDNAs containing the complete open reading frame were
generated using reverse transcription-PCR. Sequencing
showed that these cDNAs were completely identical with the
exception of a deletion of 87 nucleotides in exon 10 of the
mutant RNA (Fig. 3B). The abnormal mRNA codes for a protein
that lacks amino acids 344–372, a highly conserved region in
members of the chitinase protein family (Fig. 3B, and Ref. 3).
Transfection of COS-1 cells with wild-type chitotriosidase
cDNA resulted in secretion of enzymatically active 50-kDa
chitotriosidase, whereas parallel transfection with mutant
cDNA led to modest synthesis of a 47-kDa protein that was
largely intracellularly degraded, as was seen for cultured
macrophages. The recombinant protein that could be isolated
showed no capacity to degrade chitin or artificial substrates. It
was, however, still able to bind to chitin particles.
To establish the precise molecular defect, genomic DNA of
control subjects and chitotriosidase-deficient individuals was
studied. Relevant parts of the mutant gene were amplified by
PCR using appropriate primers (Fig. 4A, and under “Material
and Methods”). Sequence analysis revealed that in exon 10 of
the mutant gene a 24-nucleotide duplication is present (Fig.
4A). Apparently, this duplication leads to the selection of a
cryptic 39 splice site downstream in the exon, although the
authentic splice site is still intact in the mutant chitotriosidase
gene. Consistent with the findings made for macrophages of
control subjects and chitotriosidase-deficient individuals
(shown in Fig. 3A), RNase protection assays revealed that
macrophages of heterozygotes contain only a very small
amount of mutant mRNA as compared with wild-type mRNA.
These reduced levels of steady state chitotriosidase mRNA
could be due to two different reasons: (i) reduced transcription
of the mutant gene, and/or (ii) production of mRNA that is
unstable relative to wild-type chitotriosidase mRNA. Attempts
to determine half-life of mRNA following actinomycin-D treat-
ment were so far unsuccessful because of its apparent lability.
FIG. 2. Fluorescence in situ hybridization of human met-
aphase chromosomes with the genomic chitotriosidase clone.
The genomic P1 clone containing the chitotriosidase gene was hybrid-
ized to normal metaphase chromosomes as described. A, specific hybrid-
ization of the probe (arrows) is evident on chromosome 1; B, shown is an
ideogram of chromosome 1 with one of the labeled chromosomes indi-
cating that the gene is located in the region of bands q31-q32.
TABLE I
Sequences of the exon/intron junctions of the human chitotriosidase gene
Exon sequences are shown in uppercase and the intron sequences in lowercase letters. The reading frame of the cDNA sequence is indicated.
Splice-donor and -acceptor sites are shown in bold. The length of each intron is shown in parentheses. The alternative exon (11) is underlined.
Exon 1 Intron 1 Exon 2
TG.GCC.TGG.GCA.Ggtgagccgtcgg . . . (;1200 bp) . . . gtgttgctccagGT.TTC.ATG.GTC.C
Exon 2 Intron 2 Exon 3
TG.ATC.CCA.TGG.Ggtaagtagcctc . . . (;2300 bp) . . . ccaacgggccagGC.TCT.GCT.GCA.A
Exon 3 Intron 3 Exon 4
C.CTG.AAG.AAG.ATgtgagccaaagc . . . (;500 bp) . . . tgtctttcccagG.AAT.CCC.AAG.CT
Exon 4 Intron 4 Exon 5
C.GGC.ACT.CAG.AAgttagttgactg . . . (;1300 bp) . . . atcacctcacagG.TTC.ACA.GAT.AT
Exon 5 Intron 5 Exon 6
.CCC.TGG.GTA.CAGgtatggctgggc . . . (232 bp) . . . ccactcccacagGAC.TTG.GCC.AAT.
Exon 6 Intron 6 Exon 7
C.AAA.ATC.GCC.CAgtgagtctcagg . . . (;900 bp) . . . tgcctcctgcagG.AAC.CTT.GGA.TT
Exon 7 Intron 7 Exon 8
.AGC.CTC.AAC.GTGgtacgtgtggca . . . (;2500 bp) . . . ctcttccaccagGAT.GCT.GCT.GTG.
Exon 8 Intron 8 Exon 9
.GCC.TAC.TAT.GAAgtaggaaaaccc . . . (;350 bp) . . . ctgctcccacagGTC.TGC.TCC.TGG.
Exon 9 Intron 9 Exon 10
.TTC.AAA.ACC.AAGgtgaggcccagc . . . (;1300 bp) . . . ctccctgcacagGTC.AGC.TAT.CTG.
Exon 10 Intron 10 Exon 11
GG.CAG.GAA.CTG.Agtaagtaagggg . . . (364 bp) . . . ttgtgcttgcagAT.GGG.TAA.AGC.C
Exon 11 Intron 11 Exon 12
.CTT.CAG.CTG.TAGgtatggctgttg . . . (167 bp) . . . ctgtcttcccagGT.CTT.CCA.TAC.T
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The presence of the 24-bp duplication in the chitotriosidase
gene can be detected by PCR of genomic DNA with specific
primers (Fig. 4B, and “Material and Methods”). Fragments of
75 and 99 bp are amplified from the normal and mutant gene,
respectively. All chitotriosidase-deficient individuals examined
so far (n 5 26) were homozygous for the 24-bp duplication in
the chitotriosidase gene. Table II shows the results of the
analysis of chitotriosidase genotype of Ashkenazi Jewish and
Dutch individuals. It can be seen that the incidence of homozy-
gotes and heterozygotes for the duplication was about 6 and
35%, respectively, in both populations. The same mutation has
presently been detected in individuals with European (includ-
ing Dutch) (n 5 326), Jewish (n 5 68), African (n 5 10), and
Asian (n 5 20) ancestry. A study on Indonesian individuals has
indicated that the incidence of enzyme deficiency is also about
6% in this ethnic group. Genotyping of Indonesian subjects
showed that again about one in every three individuals is a
carrier for 24-bp duplication in the chitotriosidase gene.
DISCUSSION
Our investigation of the features of the chitotriosidase gene
and its RNA has been informative in a number of respects. First,
the established exon composition of the chitotriosidase gene
points out the striking similarity of the organization of this gene
FIG. 3. Defect in chitotriosidase mRNA in chitotriosidase-deficient individuals. A, detection of chitotriosidase mRNA in macrophages.
Human peripheral blood monocytes were isolated and cultured as described under “Material and Methods.” Total RNA was extracted after 10 days
and analyzed by Northern blotting as described under “Material and Methods.” Lane 1, chitotriosidase-deficient individual 1; lane 2, chitotriosi-
dase-deficient individual 2; lane 3, control individual. B, overview of the normal and mutant chitotriosidase cDNA. The positions of the signal
peptide, the catalytic (TIM-barrel) domain, and the chitin binding domain, are shown (3). The arrows indicate the primers used to generate the
complete coding sequence. The sequence of the deleted part in the mutant cDNA is shaded. The amino acids in this region that are highly conserved
among members of the chitinase protein family (see Ref. 3) are boxed.
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with that of other human genes coding for members of the chiti-
nase protein family. The exon/intron boundaries in the genes of
the human oviduct glycoproteins YKL-39 and of HCgp-39 are
very similarly located (Refs. 8, 10, and 21, and GenBank acces-
sion numbers U58001–U58010, U58514, U58515, and U49835).
This suggests that these genes have evolved by duplication
events.
The locus of the chitotriosidase gene was assigned to
1q31–32 using fluorescent in situ hybridization with the
genomic clone as probe. During the preparation of the manu-
script, Eiberg and Den Tandt (22) independently mapped the
gene to 1q31-qter by linkage analysis. The genes of all the
human members of the chitinase protein family known so far
are located on chromosome 1. According to the data deposited
in Human Gene Map of the National Center for Biotechnology
Information (NCBI), the genes of YKL-39 and the human ovi-
duct specific glycoprotein are located on 1p13 and that of HCgp-
39, like the chitotriosidase gene, is on 1q31–1q32.
FIG. 4. Defect in the chitotriosidase gene in chitotriosidase-deficient individuals. A, overview of the relevant part of the chitotriosidase
gene. Upper part (AI) shows the normal chitotriosidase gene. The arrows indicate the primers used for amplification of the genomic DNA. The lines
above the gene show the normal splicing in which exon 11 is skipped. Lower part (AII) shows the difference in the mutant chitotriosidase gene. The
mutant gene contains a 24-bp duplication in exon 10. Above the genes the difference in splicing is depicted. The relevant nucleotide sequences are
shown. The vertical arrow indicates the activated 39 splice site in the mutant gene. The 24-bp fragment in the normal gene and the 48-bp fragment
in the mutant gene are underlined. B, detection of the 24-bp duplication in the chitotriosidase gene by PCR of genomic DNA. Amplified fragments
(primers Chs9 and Chas8) were separated on a native 10% polyacrylamide gel and stained with ethidium bromide. The size of the fragments of
the normal and mutant allele is 75 and 99 bp, respectively. Lane 1, homozygote mutant; lanes 2-4, 6, and 8, homozygote wild type; and lanes 5 and
7, heterozygote. The additional larger fragment that is only present in the case of heterozygotes is because of formation of a hybrid DNA molecule,
consisting of a normal and a mutant strand. wt, wild-type
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The nature of the common deficiency in chitotriosidase ac-
tivity was elucidated in this study. The defect was found to be
a 24-bp duplication that activates a cryptic 39 splice site in the
same exon, causing the formation of mRNA with an in-frame
internal deletion of 87 nucleotides. Similar mutations affecting
splice site selection have been reported earlier for two lysoso-
mal hydrolases, the b-subunit of b-hexosaminidase and aryl-
sulfatase A, and for episialin (23–25).
Based on the incidence of deficiency of chitotriosidase activ-
ity in The Netherlands and among Ashkenazim of about 6%,
the Hardy-Weinberg equilibrium predicts that 37% of the pop-
ulation will be carriers of a mutant chitotriosidase gene. This
prediction corresponds very well with the observed frequency of
carriers of the 24-bp duplication in the chitotriosidase gene.
This and the finding that all chitotriosidase-deficient individ-
uals so far are homozygous for the duplication indicate that
this mutation must be the predominant cause of chitotriosidase
deficiency. The multi-ethnic occurrence and prevalence of the
24-bp duplication in the chitotriosidase gene suggests that it
probably originated before the radiation of tribal populations
that have formed the present ethnic groups.
Cultured macrophages of chitotriosidase-deficient individu-
als contain very little mRNA and secrete almost no chitotrio-
sidase protein. We have not been able to detect the mutant
protein in plasma of chitotriosidase-deficient individuals, in-
cluding Gaucher patients. Analysis of recombinant-produced
mutant chitotriosidase indicated that the protein is enzymati-
cally inactive. The mutant chitotriosidase is predicted to lack
amino acids 344–372. For several homologous chitinases, the
three-dimensional structure has been resolved by crystallo-
graphic analysis (26, 27). The catalytic core structure of these
hydrolases is thought to be an 8-stranded a/b (TIM) barrel (26–
28). On the basis of its homology with these chitinases, it can be
predicted that the internal deletion in the mutant chitotriosidase
will prevent the formation of a proper TIM-barrel conformation.
In view of this, it is not surprising that the recombinant produced
mutant protein shows no chitinolytic activity. On the basis of all
our findings, it seems extremely unlikely that the mutant chi-
totriosidase allele renders a functional protein.
Given the high incidence of chitotriosidase deficiency, it
could be argued that the enzyme is redundant in man. How-
ever, it is unattractive to assume that the enzyme does no
longer fulfill any function. The role of the homologous chiti-
nases in plants in defense against fungal pathogens has been
demonstrated convincingly (6, 7, 29–34). The structural fea-
tures of chitinases have been extremely well conserved in chi-
totriosidase. Furthermore, the expression of the enzyme in
phagocytes is regulated in a remarkable manner. It seems
therefore likely that chitotriosidase still fulfills a role, but that
a deficiency can be somehow compensated. A comparison with
the closely related lysozyme is of interest. The bactericidal
function of this hydrolase is well established; nevertheless, in
rabbits an inherited deficiency in lysozyme occurs that seems
to have little consequence for susceptibility to infections (35).
The diverse array of defense mechanisms of the immune sys-
tem in mammals probably renders sufficient tolerance to de-
fects in single enzymes such as lysozyme and chitotriosidase. In
this connection, it will be of interest to determine whether the
chitotriosidase genotype of immunocompressed individuals is
predictive for their risk on infections with fungal pathogens.
It is intriguing to understand why the mutation in the chi-
totriosidase gene occurs with such high incidence in different
ethnic groups. This could point to some selective advantage for
carriers, but at present there are no clues for the nature of such
a selective factor. In this connection, it will be essential to obtain
detailed insight in the physiological role(s) of chitotriosidase and
the mechanism(s) that can compensate for its absence.
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TABLE II
Chitotriosidase genotype distribution
The chitotriosidase genotype of unrelated Ashkenazi Jewish and
Dutch subjects was determined as described under “Materials and
Methods.”
Population
Genotype
Wild-type Heterozygotemutant
Homozygote
mutant
%
Dutch (n 5 171) 58.5 35.1 6.4
Ashkenazi Jewish (n 5 68) 60.3 33.8 5.9
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